Valuation Caplin Point Laboratories Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. Other stock markets 19:05:08 04/08/2026 HKT			5-day change	1st Jan Change
2,571.90 ^INR	+0.23%		-0.63%	+39.92%

05-15	Caplin Point Laboratories Limited, Q4 2026 Earnings Call, May 14, 2026
05-15	Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	30,571	51,529	45,291	100,038	152,221	195,380	-	-
Change	-	68.55%	-12.11%	120.88%	52.16%	28.35%	-	-
Enterprise Value (EV)	30,571	51,529	45,291	100,038	152,221	195,380	195,380	195,380
Change	-	68.55%	-12.11%	120.88%	52.16%	28.35%	0%	0%
P/E	12.7x	17.3x	12.1x	22x	28.5x	17.9x	27.4x	24x
PBR	2.58x	3.47x	2.41x	4.32x	5.34x	3.19x	4.44x	4.03x
PEG	-	0.7x	0.5x	1x	1.6x	0.9x	1.7x	1.7x
Capitalization / Revenue	2.88x	4.06x	3.09x	5.91x	7.86x	5.23x	7.85x	6.96x
EV / Revenue	0x	0x	0x	0x	0x	9.18x	7.85x	6.96x
EV / EBITDA	0x	0x	0x	0x	0x	26.3x	22.7x	19.9x
EV / EBIT	0x	0x	0x	-	0x	25.1x	21x	18.2x
EV / FCF	0x	0x	0x	0x	0x	51.4x	35.5x	36.1x
FCF Yield	6.39%	4.77%	1.72%	1.73%	1.58%	2.4%	2.82%	2.77%
Dividend per Share ²	3	2	2	2.5	3	-	4	4
Rate of return	0.74%	0.29%	0.34%	0.19%	0.15%	-	0.16%	0.16%
EPS ²	31.71	39.26	49.18	59.9	70.25	84.11	93.8	107
Distribution rate	9.46%	5.09%	4.07%	4.17%	4.27%	-	4.26%	3.74%
Net sales ¹	10,613	12,694	14,667	16,941	19,375	21,872	24,880	28,053
EBITDA ¹	3,286	3,947	4,411	5,514	6,469	7,609	8,604	9,810
EBIT ¹	3,152	3,478	4,520	-	5,810	8,036	9,321	10,752
Net income ¹	2,423	2,998	3,763	4,571	5,363	6,412	7,128	8,124
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	404.15	679.90	596.70	1,317.30	2,002.60	2,570.40	2,570.40	2,570.40
Nbr of stocks (in thousands)	75,643	75,789	75,903	75,942	76,012	76,012	-	-
Announcement Date	6/5/21	12/5/22	27/5/23	16/5/24	15/5/25	14/5/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	36x	6.81x	23.52x	0.86%	49.43B
OTSUKA HOLDINGS CO., LTD.	18.53x	2.15x	9.92x	1.35%	38.54B
CIPLA LIMITED	28.7x	3.5x	18.14x	0.88%	12.5B
ZYDUS LIFESCIENCES LIMITED	26.57x	3.92x	15.96x	0.59%	11.73B
KRKA, D. D.	19.11x	3.34x	11.99x	3.48%	9.09B
ONO PHARMACEUTICAL CO., LTD.	15.39x	1.98x	6.18x	3.35%	7.01B
GEDEON RICHTER	8.33x	1.96x	5.12x	5.2%	6.86B
GLENMARK PHARMACEUTICALS LIMITED	33.85x	3.85x	16.4x	0.24%	6.6B
Average	23.31x	3.44x	13.40x	2%	17.72B
Weighted average by Cap.	26.29x	4.18x	15.90x	1.45%